Learning objectives are:

1. Access completed studies and databases providing information about the most common genomic variants found in pediatric malignancies

2. Understand ongoing trials evaluating the clinical impact of the precision cancer medicine approach

3. Apply a multi-disciplinary and evidence-based approach to linking gene variants to potential activity of targeted therapy in interpreting sequencing results


Session date: 
09/28/2017 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Katherine Janeway, MD